- \r\n \t
- Mood Spectrum<\/li>\r\n \t
- Severe Mania<\/li>\r\n \t
- Hypomania<\/li>\r\n \t
- Euthymia<\/li>\r\n \t
- Melancholy<\/li>\r\n \t
- Severe Melancholy<\/li>\r\n<\/ul>\r\nAssessment\r\n
- \r\n \t
- agitation, sadness, speech<\/li>\r\n \t
- energy, cognition, functional impairment<\/li>\r\n \t
- mental status assessment<\/li>\r\n \t
- suicidal ideation<\/li>\r\n \t
- must monitor for adverse effects of medication treatment such as serotonin symptoms suicidal ideation<\/li>\r\n<\/ul>\r\nManagement\r\n
- \r\n \t
- improvement of social determinants of health<\/li>\r\n \t
- mental status exam and screening instruments<\/li>\r\n \t
- psychotherapy pharmacotherapy (antidepressants, anti-mania, antipsychotics, CNS depressants)<\/li>\r\n<\/ul>\r\nConsequences\r\n
- \r\n \t
- High use of medical care<\/li>\r\n \t
- Potential for suicide<\/li>\r\n \t
- Social and relational impacts<\/li>\r\n \t
- Cognitive impacts<\/li>\r\n<\/ul>\r\nPhysiological Process\r\n
- \r\n \t
- Cerebral Cortex\r\n
- \r\n \t
- reduced blood flow and abnormal phosphorous metabolism (especially in the prefrontal cortex)<\/span><\/li>\r\n<\/ul>\r\n<\/li>\r\n \t
- Neurotransmitters\r\n
- \r\n \t
- Dopamine<\/span><\/li>\r\n \t
- Serotonin<\/span><\/li>\r\n \t
- Norepinephrine<\/span><\/li>\r\n<\/ul>\r\n<\/li>\r\n<\/ul>","rendered":"
![\"concept](\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2021\/12\/Screen-Shot-2022-03-31-at-1.44.24-PM.png\")
<\/p>\nImage Description<\/h3>\n
Mood and affect concept map description:<\/strong> This is a concept map that shows the components of mood and affect. It starts with the definition: the way a person feels and acts. And then continues with the components of mood and affect:<\/p>\n
Scope<\/p>\n
- \n
- Mood Spectrum<\/li>\n
- Severe Mania<\/li>\n
- Hypomania<\/li>\n
- Euthymia<\/li>\n
- Melancholy<\/li>\n
- Severe Melancholy<\/li>\n<\/ul>\n
Assessment<\/p>\n
- \n
- agitation, sadness, speech<\/li>\n
- energy, cognition, functional impairment<\/li>\n
- mental status assessment<\/li>\n
- suicidal ideation<\/li>\n
- must monitor for adverse effects of medication treatment such as serotonin symptoms suicidal ideation<\/li>\n<\/ul>\n
Management<\/p>\n
- \n
- improvement of social determinants of health<\/li>\n
- mental status exam and screening instruments<\/li>\n
- psychotherapy pharmacotherapy (antidepressants, anti-mania, antipsychotics, CNS depressants)<\/li>\n<\/ul>\n
Consequences<\/p>\n
- \n
- High use of medical care<\/li>\n
- Potential for suicide<\/li>\n
- Social and relational impacts<\/li>\n
- Cognitive impacts<\/li>\n<\/ul>\n
Physiological Process<\/p>\n
- \n
- Cerebral Cortex\n
- \n
- reduced blood flow and abnormal phosphorous metabolism (especially in the prefrontal cortex)<\/span><\/li>\n<\/ul>\n<\/li>\n
- Neurotransmitters\n
- \n
- Dopamine<\/span><\/li>\n
- Serotonin<\/span><\/li>\n
- Norepinephrine<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n
Media Attributions<\/h2>
- Screen Shot 2022-03-31 at 1.44.24 PM <\/li><\/ul><\/div>","protected":false},"author":1267,"menu_order":7,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":[],"pb_section_license":""},"chapter-type":[],"contributor":[],"license":[],"class_list":["post-1047","chapter","type-chapter","status-publish","hentry"],"part":1017,"_links":{"self":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/1047","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/users\/1267"}],"version-history":[{"count":3,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/1047\/revisions"}],"predecessor-version":[{"id":2689,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/1047\/revisions\/2689"}],"part":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/parts\/1017"}],"metadata":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/1047\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/media?parent=1047"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapter-type?post=1047"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/contributor?post=1047"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/license?post=1047"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
- Serotonin<\/span><\/li>\n
- Neurotransmitters\n
- reduced blood flow and abnormal phosphorous metabolism (especially in the prefrontal cortex)<\/span><\/li>\n<\/ul>\n<\/li>\n
- Cerebral Cortex\n
- Serotonin<\/span><\/li>\r\n \t
- Neurotransmitters\r\n
- reduced blood flow and abnormal phosphorous metabolism (especially in the prefrontal cortex)<\/span><\/li>\r\n<\/ul>\r\n<\/li>\r\n \t
- Cerebral Cortex\r\n